Shares in Russian companies 36.6 and Veropharm surged in Monday afternoon trading on the Moscow Stock Exchange on news the competition watchdog, the FAS, had cl 14 November 2012
AFK Sistema, the financial conglomerate owned by the Russian billionaire Vladimir Yevtushenko, is considering acquiring Veropharm, Russia's third largest drugma 6 November 2012
US drugmaker Forest Laboratories (NYSE: FRX) has entered into a broad strategic alliance with Brazil-based pharma firm moksha8 that will provide Forest with a c 24 October 2012
Global drugs behemoth Pfizer (NYSE: PFE) revealed yesterday that it is prepared to pay up to $680 million to acquire USA-based, privately-held NextWave Pharmace 23 October 2012
India's second largest drugmaker Dr Reddy's Laboratories (NYSE: RDY) announced this morning that it intendeds to make a public offer to acquire the issued and o 22 October 2012
Privately-held US drugmaker Alvogen last Friday entered into an agreement to acquire a majority share in South Korea-based generic drugs manufacturer and market 21 October 2012
Following speculation that started last month, India's SMS Pharmaceuticals this week confirmed that it has sold its manufacturing units in Visakhapatnam, Andhra 18 October 2012
The USA's Federal Trade Commission will require Watson Pharmaceuticals (NYSE: WPI) and fellow generic drugmaker Actavis to sell the rights and assets to 18 drug 16 October 2012
Channel Islands-based private equity firm Cinven has reached agreement to acquire UK-based niche generic drugmaker Amdipharm from Vijay and Bhikhu Patel, the In 15 October 2012
USA-based BioSante Pharmaceuticals (Nasdaq: BPAX) and privately-held specialty and generic drugmaker ANI Pharmaceuticals have entered into a definitive all-stoc 5 October 2012
Par Pharmaceuticals (NYSE: PRX), a USA-based maker of generic drugs and niche innovative proprietary pharmaceuticals, and US private equity group TPG have annou 1 October 2012
Mallinckrodt, the soon to be spun-out pharmaceuticals business of Ireland-based Covidien (NYSE: COV), has signed a definitive agreement to acquire CNS Therapeut 25 September 2012
Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceuticals (SSE Code: 600267), a leading Chinese pharmaceutical company, have announced the lau 14 September 2012
Cinven, a Channel Islands-based private equity firm, said last Friday that it has reached agreement to acquire UK specialty drugmaker Mercury Pharma, as a platf 20 August 2012
Leading drug multinationals, including global behemoth Pfizer (NYSE: PFE) and Swiss major Novartis (NOVN: VX) are reportedly considering acquiring India-based 20 August 2012
German drugmaker Stada Arzneimittel (SAZ: GR) revealed this week that it has signed a contract and accompanying temporary service contracts on the sale of two R 16 August 2012
Indian drugmaker Sun Pharmaceutical Industries (SUN: BO) says that it has now reached agreement to acquire Israel-based Taro Pharmaceutical Industries (PinkShee 14 August 2012
Italian drugmaker Recordati (RC: MI) said yesterday that it has signed an agreement to acquire 100% of the share capital of Farma-Projekt Sp zoo, a Polish pharm 3 August 2012
The USA's Federal Trade Commission said yesterday that it will require Swiss drug major drug Novartis (NOVN: VX) to give up its marketing rights to four topical 17 July 2012
Par Pharmaceutical (NYSE: PRX), a USA-based maker of generic drugs and niche innovative proprietary pharmaceuticals, has entered into a definitive merger agreem 17 July 2012
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news